Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats

Hypertension

Volumn 27, Issue 1, 1996, Pages 49-55

  Sventek, Pavol ^a   Li, Jin S ^a   Grove, Kevin ^a   Deschepper, Christian F ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

aorta; endothelium derived relaxing factor; nitric oxide; resistance arteries

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RENIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; GENE EXPRESSION; HEART HYPERTROPHY; HEART WEIGHT; MALIGNANT HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030022834     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.1.49     Document Type: Article

References (44)

1. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension. 1993;21:747-751.
2. Lüscher TF, Seo B, Bühler FR. Potential role of endothelin in hypertension. Hypertension. 1993;21:752-757.
3. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995;25:1135-1143.
4. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
5. Larivière R, Day R, Schiffrin EL. Increased expression of endothelin-l gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1993;21:916-920.
6. Day R, Larivière R, Schiffrin EL. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticoslerone acetate-salt hypertensive rats. Am J Hypertens. 1995;8:294-300.
7. Larivière R, Deng LY, Day R, Sventek P, Thibault G, Schiffrin EL. Increased endothelin-1 gene expression in the endothelium of coronary arteries and in the endocardium of DOCA-salt hypertensive rats. J Mol Cell Cardiol. 1995;27:2123-2131.
8. Schiffrin EL, Larivière R, Li J-S, Sventek P, Touyz RM. Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive: rats. Hypertension. 1995;25(pt 2):769-773.
9. Li J-S, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension. 1994;24:183-188.
10. Schiffrin EL, Sventek P, Li J-S, Turgeon A, Reudelhuber T. Anti-hypertensivc effect of bosentan, a mixed ETA/ETB endothelin receptor antagonist, in DOCA-salt spontaneously hypertensive rats. Br J Pharmacol. 1995;115:1377-1381.
11. Deng LY, Schiffrin EL. Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in the rat. Am J Physiol. 1991;261:H1171-H1177.
12. Deng LY, Schiffrin EL. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am J Physiol. 1992;262: H1782-H1787.
13. Larivière R, Sventek P, Thibault G, Schiffrin EL. Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats. Life Sci. 1995;56:1889-1896.
14. Deng LY, Schiffrin EL. Effects of endothelin-1 and vasopressin on small arteries of spontaneously hypertensive rats. Am J Hypertens. 1992;5:817-822.
15. Li J-S, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension. 1995;25(pt 1):495-500.
16. Li J-S. Schiffrin EL. Chronic endothelin receptor antagonist: treatment of youna spontaneously hypertensive rats. J Hypertens. 1995;13:647-652.
17. Deng LY, Thibault G, Schiffrin EL. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens. 1993;15:527-537.
18. Li J-S, Schiffrin EL. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens. 1994;7:996-1004.
19. Dunn WR, Gardiner SM. No evidence of vascular remodeling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens. 1995;13:849-857.
20. Schiffrin EL. Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens. 1995;13:817-821. Editorial.
21. Brockway BP, Mills PA, Azar SH. A new method for continuous chronic recording of blood pressure, heart rate and activity in the rat via radiotelemetry. Clin Exp Hypertens. 1991;A13:885-895.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
23. Sakurai T, Yanagisawa M, Inoue A, Ryan US, Kiura S, Mitsui Y, Goto K, Masaki T. cDNA cloning, sequencing analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun. 1991;175:44-47.
24. Torczynski R, Bollon AP, Fuke M. The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res. 1983;11:4879-4890.
25. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens. 1991;4:303-308.
26. B endothelin receptor antagonist bosentan. Can J Physiol Pharmacol. 1995;73:390-398.
27. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 1989; 78:225-228.
28. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 1990;258:C408-C415.
29. Schiffers PMH, Fazzi GE, Van Ingen Schenau D, De Mey JGR. Effects of candidate autocrine and paraeríne mediators on growth responses in isolated rat arteries. Arterioscler Thromb. 1994;14: 420-426.
30. Arnal JF, El Amrani A-I, Chatellier G, Ménard J, Michel J-B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
31. Jover B, Herizi A, Ventre F, Dupon M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
32. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bronno-cyclic guanosine monophosphate inhibit milogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
33. G-Nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Cric Res. 1993;72:387-395.
34. Ashkenazi A, Ramachandran J, Capon DJ. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes. Nature. 1989;340:146-150.
35. Pínkas-Kramarski R, Stein R, Lindenboim L, Sokolovsky M. Growth factor-like effects mediated by muscarinie receptors in PC12M1 cells. J Neurochem. 1992;59:2158-2166.
36. Mazza E, Ghigo E, Boffano G, Valetto M, Maccario M, Arvat E, Bellone J, Procopio M, Muller EE, Camanni F. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. Eur J Pharmacol. 1994;254:17-20.
37. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
38. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Haniaoki M, Kato H, Yazaki Y. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1989;159:1435-1440.
39. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19:753-757.
40. Schini VB, Hendrickson H, Heublin DM, Burnett JC Jr, Vanhoutte PM. Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol. 1989;165:333-334.
41. MacArthur H, Warner TD, Wood EG, Corder R, Vane JR. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem Biophys Res Commun. 1994;200:395-400.
42. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension. 1995;25:449-452.
43. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99-104.
44. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest. 1993;92:2080-2085.